Kernel’s Brain-Imaging Helmet Approved For Clinical Trial On Patients Using Ketamine
An LA-based company called Kernel developed a brain-imaging helmet that can track what actually happens in the brain during a psychedelic trip.
The device, called Kernel Flow, was just approved by the FDA to be used in a ketamine trial sponsored by Cybin (CYBN).
Researchers will use the helmet to measure the neurological activity of 15 patients during a ketamine therapy session compared to baseline activity.
Kernel Flow is much less expensive than other brain-imaging tools and allows the patients to move freely during the session.